MedPath

Impact of Interface With/Without Oral Appliance of Sleep Apnea Treatment

Not Applicable
Terminated
Conditions
Obstructive Sleep Apnea
Registration Number
NCT01889472
Lead Sponsor
Laval University
Brief Summary

CPAP is the most effective treatment of obstructive sleep apnea. Oro-nasal masks may be used in case of mouth leaks but these are associated with higher positive pressure needs and lower compliance to treatment. The present investigation evaluates if CPAP compliance would increase when an oral appliance is used in combination with a nasal mask compared to the use of an oro-nasal mask. Eligible patients are those demonstrating a low compliance when using an oro-nasal mask during CPAP therapy. Patients will be treated with automatic CPAP with one of the above-detailed interfaces for 4 weeks and data will be extracted from the machine report in each condition.

Detailed Description

Participating subjects will be currently treated by CPAP and low compliance will be assessed according to machine report download demonstrating 3h or less of CPAP usage per night.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • normal nasal breathing
  • dentition allowing for use of an oral appliance
  • absence of mandibular joint pathology
  • Patients requiring the use of a facial mask during CAPP titration due to presence of mouth leaks with a nasal/prong interface
  • Patients using CPAP less than 3 hours/day as prescribed following CPAP titration
Exclusion Criteria
  • Clinical instability
  • smoking cessation
  • current weight loss strategy
  • Marked anatomic abnormalities of upper airway (i.e. macroglossia, tonsils hypertrophy)
  • severe cardio-metabolic co-morbidity

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
CPAP complianceAfter 4 weeks of CPAP trial

CPAP compliance will be assessed according to machine report download for the 4 weeks of treatment in each study condition.

Secondary Outcome Measures
NameTimeMethod
diurnal somnolenceAfter 4 weeks of CPAP trial

Epworth Sleepiness Score

Trial Locations

Locations (3)

CHUM

🇨🇦

Montreal, Quebec, Canada

IUCPQ

🇨🇦

Quebec, Canada

AGIRADOM

🇫🇷

Grenoble, France

CHUM
🇨🇦Montreal, Quebec, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.